Low testosterone at first prostate-specific antigen failure and assessment of risk of death in men with unfavorable-risk prostate cancer treated on prospective clinical trials-Reference-Cited by-同舟云学术

Low testosterone at first prostate-specific antigen failure and assessment of risk of death in men with unfavorable-risk prostate cancer treated on prospective clinical trials

Published:2017-12-20 Issue:7 Volume:124 Page:1383-1390
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Atkins Katelyn M.¹^ORCID,Chen Ming-Hui²,Wu Jing³,Renshaw Andrew A.⁴^ORCID,Loffredo Marian⁵,Kantoff Philip W.⁶^ORCID,Small Eric J.⁷,D'Amico Anthony V.⁵

Affiliation:

1. Harvard Radiation Oncology Program; Dana-Farber Cancer Institute and Brigham and Women's Hospital; Boston Massachusetts

2. Department of Statistics; University of Connecticut; Storrs Connecticut

3. Department of Computer Science and Statistics; University of Rhode Island; Kingston Rhode Island

4. Department of Pathology; Baptist Hospital and Miami Cancer Institute; Miami Florida

5. Department of Radiation Oncology; Dana-Farber Cancer Institute and Brigham and Women's Hospital; Boston Massachusetts

6. Department of Medicine; Memorial Sloan Kettering Cancer Center; New York New York

7. Department of Medicine; University of California at San Francisco; San Francisco California

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference30 articles.

1. Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial;D'Amico;JAMA,2008

2. Duration of androgen suppression in the treatment of prostate cancer;Bolla;N Engl J Med,2009

3. Radiotherapy and short-term androgen deprivation for localized prostate cancer;Jones;N Engl J Med,2011

4. Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy;Freedland;JAMA,2005

5. Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes;Agarwal;Cancer.,2008

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic impact of serum testosterone in metastatic hormone-naive prostate cancer: a systematic review and meta-analysis;Current Opinion in Urology;2023-09-25

2. Prostate‐specific antigen nadir and testosterone level at prostate‐specific antigen failure following radiation and androgen suppression therapy for unfavorable‐risk prostate cancer and the risk of all‐cause and prostate cancer–specific mortality;Cancer;2021-04-06

3. Time to Prostate-specific Antigen Nadir and the Risk of Death From Prostate Cancer Following Radiation and Androgen Deprivation Therapy;Urology;2019-04

4. IS TESTOSTERONE PROGNOSTIC IN PROSTATE CANCER TREATMENT? THE UROLOGICAL STANDPOINT;ACTA CLIN CROAT;2019

5. New Insights into Ejaculatory Frequency and Prostate Cancer Risk: Association, Causation, or What Do We Have to Lose?;European Urology;2018-11